Cutler Group LP Applied Genetic Technologies Corp Transaction History

Cutler Group LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Jan 21, 2021	SELL	$3.99 - $5.7 $798 - $1,140	-200 Reduced 9.09%	2,000 $8,000
Q3 2020 Oct 27, 2020	BUY	$4.38 - $6.43 $6,570 - $9,645	1,500 Added 214.29%	2,200 $10,000
Q2 2020 Jul 22, 2020	BUY	$3.0 - $6.9 $900 - $2,070	300 Added 75.0%	700 $3,000
Q4 2019 Feb 06, 2020	BUY	$2.69 - $4.92 $1,076 - $1,968	400 New	400 $1,000

Ticker AGTC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 67,632,200
Description
Applied Genetic Technologies Corporation, a clinical-stage biotechnology company, develops transformational genetic therapies for patients suffering from rare and debilitating diseases. Its advanced product candidates include three ophthalmology development programs across two targets, including X-linked retinitis pigmentosa, which is in the Pha...

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

Stay updated on Cutler Group LP with notifications on news.